文献速递其他结缔组织病

引入以家长为中心的儿童皮肌炎远程监测复合疾病活动度评分

Introducing a parent-centred composite disease activity score for remote monitoring in juvenile dermatomyositis.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

本研究基于家长报告结局(PROs)开发并验证了儿童皮肌炎(JDM)复合疾病活动度评分ParJDMAI,包含四项PROs,总分0-40分。在多中心254例JDM患者中按OMERACT标准验证,显示良好的结构效度、内部一致性(Cronbach's alpha 0.86)和区分能力(P < 0.001),且与医生评估强相关,有望作为远程监测工具。

要点

  • ParJDMAI基于四项家长报告结局,总分0-40分,完成时间<10分钟。
  • 在254例JDM患者中验证,Cronbach's alpha 0.86,探索性因子分析识别一个特征值2.9的因子。
  • 能强区分医生评估的疾病活动状态(P < 0.001),与医生中心测量强相关。

核心结论

  • ParJDMAI可行且具有良好的测量特性,可能作为医生评估的替代指标,通过数字技术完成可用于构建远程患者监测项目。

研究设计与样本

  • 多中心样本254例JDM患者,按照OMERACT结局测量过滤器进行验证程序。

主要发现

  • ParJDMAI简短简单,完成和评分时间<10分钟。
  • 验证分析显示良好的结构效度、满意的内部一致性(Cronbach's alpha 0.86)和结构(探索性因子分析明确识别一个特征值2.9的因子)。
  • 能强区分医生估计的疾病活动状态(P < 0.001)。
  • 对临床重要变化随时间有公平的反应性(标准化反应均值为0.8,在家长判断为改善的患者中)。
  • ParJDMAI与医生中心的疾病活动度测量强相关。

关键数值与推荐

  • ParJDMAI包含四项家长报告结局:疾病活动度整体评估、疲劳评估、肌肉疾病活动度评估、皮肤疾病活动度评估。
  • 每项按0-10分加权,总分范围0-40分。

临床怎么用

  • ParJDMAI可通过数字技术完成,可能为构建远程患者监测项目提供可靠且务实的方法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The objective of this study was to develop and test a composite DAS for JDM solely based on parent-reported outcomes (PROs). METHODS: The parent JDM Activity Index (ParJDMAI) includes the following four PROs: (1) global assessment of disease activity; (2) assessment of fatigue; (3) assessment of muscle disease activity; (4) assessment of skin disease activity. Each item is weighted on a 0-10 scale, which yields a total score ranging from 0 to 40. Validation procedures were conducted on a multicentre sample of 254 patients with JDM according to the OMERACT filter for outcome measures in rheumatology. RESULTS: The ParJDMAI is short and simple, and is quick, taking <10 minutes to complete and score, which makes it practical for use in standard clinical care. In validation analyses, the tool demonstrated good construct validity, satisfactory internal consistency (Cronbach's alpha 0.86) and structure (with unambiguous identification of one factor with eigenvalue 2.9 on exploratory factor analysis), strong ability to discriminate between physician-estimated disease activity states (P < 0.001), and fair responsiveness to clinically important change over time (standardized response mean 0.8 among patients judged as improved by the parents). The ParJDMAI correlated strongly with physician-centred measures of disease activity. CONCLUSION: The ParJDMAI was found to be feasible and to possess good measurement properties. It also proved to potentially serve as a surrogate for physicians' evaluations. Completion of the ParJDMAI through digital technologies may provide a reliable and pragmatic approach for building a remote patient-monitoring program.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Tarantola L, Rebollo-Giménez AI, Sciutto A, et al. Introducing a parent-centred composite disease activity score for remote monitoring in juvenile dermatomyositis. Rheumatology (Oxford). 2026. PMID: 41978918. doi:10.1093/rheumatology/keag192

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。